Page 292 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 292

Chapter 22  Natural Killer Cell Immunity  243


            MHC-dependent processing termed licensing, NK cells that express   and responsiveness to cytokine stimulation. Population studies have
            receptors for self MHC exhibit greater responsiveness to stimulation;   subsequently suggested that the H48 allele may be necessary but not
            however, their effector function against normal cells is blocked by   sufficient to produce clinical disease. 86
                                                                                                                    +
                                                77
            engagement of inhibitory receptors for self MHC.  Whether respon-  Clinical  examples  of  patients  entirely  lacking  any  CD56
            siveness  is  determined  by  interaction  with  cells  expressing  ligands   lymphocyte  subsets  have  been  reported. The  first  report  was  of  a
            for  NK  cell  receptors  (so-called  arming)  or  hyporesponsiveness  is   young  patient  who  presented  with  life-threatening  varicella  infec-
            induced  via  encounters  with  normal  cells  lacking  MHC  ligands   tion. She subsequently developed CMV pneumonia and cutaneous
            (“disarming”  or  “anergy”)  is  unclear;  however,  experimental  data   HSV infection. Analysis of her lymphocyte subsets demonstrated a
                                                                                                      +
                                                                                                               +
                                                                                                                    5
            suggest that persistent stimulation results in hyporesponsiveness but   striking and selective absolute absence of CD56  or CD16  cells.
            persistent stimulation with concomitant inhibition leads to NK cell   The patient went on to develop aplastic anemia and died as a result
                                                                                                 86
            responsiveness. 78,79  Studies such as these and others suggest that NK   of  complications  of  stem  cell  transplant.   A  second  patient  who
            cells may be sensitive to changes in the microenvironment and may   presented  with  disseminated  Mycobacterium  avium  went  on  to  die
                                                                                              87
            modulate responsiveness to stimuli.                   as  a  result  of  disseminated  varicella.   Other  patients  have  been
                                                                                                     +
                                                                                                          −
                                                                  described with an isolated deficiency of CD56 /CD3  lymphocytes
                                                                                                                    +
                                                                                                               +
                                                                  but  with  normal  or  even  increased  populations  of  CD56 /CD3
            Natural Killer Cell Memory                            cells. One such patient presented with severe, recurrent human papil-
                                                                                                  88
                                                                  loma  virus–related  condylomatous  disease.   Although  the  genetic
            Immunologic  memory  has  long  been  reserved  as  a  process  of  the   mechanisms of these diseases remain unknown, they highlight the
            adaptive immune system; however, recent data suggest that NK cells   functional role of NK cells in providing immunity toward infectious
            possess a form of memory as well. This idea was first demonstrated   pathogens.
            in a recombinase-activating gene 1 (RAG-1)-deficient mouse lacking   NK cell deficiencies have been described as a component of other
            T and B cells. Hapten-induced hypersensitivity was mediated by NK   disease processes affecting multiple hematopoietic and immune lin-
            cells in this model, and “memory” NK cells were described as residing   eages. The genetic deficiencies responsible for many of these disorders
            in the liver and bearing Thy1 and CXCR6 on their surfaces. 80  have been described and can be found in Table 22.2.
              This concept has also been demonstrated in the setting of viral
            infection in mice with vesicular stomatitis virus, HIV-1, influenza,
            and murine CMV (MCMV). 80,81  In regard to MCMV, for instance,   The Role of Natural Killer Cells in Autoimmunity
                 +
            Ly49H   NK  cells  recognize  MCMV  m157  glycoprotein,  resulting
                                                          +
            in  NK  cell–mediated  control  of  the  disease.  These  Ly49H   NK   Interestingly,  NK  cells  have  been  implicated  in  both  the  regula-
            cells  preferentially  expand  in  the  setting  of  infection  and  contract   tion  and  the  pathogenesis  of  autoimmune  disorders.  For  example,
            after  infection  is  controlled.  However,  “memory”  NK  cells  could   in a murine experimental autoimmune encephalomyelitis model of
            be detected months after infection, and, upon restimulation, these   multiple  sclerosis  in  which  disease  is  induced  with  myelin  oligo-
            NK cells exhibited augmented cytotoxicity and cytokine production   dendrocyte glycoprotein (MOG), NK depletion leads to enhanced
                        81
            against MCMV.  Although a unique marker of memory is unclear,   T-cell  response  to  MOG.  Similarly,  in  human  multiple  sclerosis,
            these NK cells stably express KLRG1, a cadherin-recognizing inhibi-  NK cells have been implicated in the maintenance of disease remis-
                                                                     89
            tory receptor, and could be detected 2 months after infection control   sion.  NK cells have also been shown to control inflammation in
                                                                                                    90
            even in adoptive transfer models. 81                  an experimental model of autoimmune colitis.  NK cells may exert
              A third demonstration of functional NK cell memory has been   this effect through recognition and elimination of T cells activated
            reported whereby human NK cells preactivated after brief exposure   against autoantigens. 91
            to IL-12, IL-15, and IL-18. These cells showed an enhanced response   There are also examples of NK cells promoting autoimmune dis-
            to restimulation up to 3 weeks later that also was retained in divid-  orders. For instance, experimental evidence supports the idea that NK
                      82
            ing  NK  cells.   This  subset  was  associated  with  CD94,  NKG2A,   cells may promote development of type 1 diabetes mellitus through
                                                                                                                   92
            NKG2C, and CD69 expression and lacked KIR and CD57.   targeted elimination of pancreatic islet β cells after viral infection.
                                                                  This pathobiology may be mediated via an as yet unidentified NKp46
                                                                                              73,93
            THE ROLE OF NATURAL KILLER CELLS IN                   ligand located in the insulin granules.   Other studies suggest that
                                                                  NK cells can promote humorally mediated autoimmune diseases such
            HUMAN DISEASE                                         as myasthenia gravis through potentiation of autoreactive B cells.
                                                                                                                   94
                                                                  Synoviocytes of patients with rheumatoid arthritis (RA) have been
            NK cell deficiencies are rare; however, such conditions provide insight   shown  to  express  abnormally  high  levels  of  MICA,  the  previously
            into  the  role  NK  cells  play  in  response  to  infectious  pathogens,   described ligand for NKG2D. 95,96  In fact, NK cells present in acute
            autoimmune disorders, and the development of malignancy. Selec-  RA joint effusions may perpetuate this autoimmune inflammatory
            tive  NK  cell  deficiency  has  not  been  associated  with  a  particular   response. 97
                          83
            Mendelian disorder ; however, studies have shed new light on the   Finally, NK cell receptor polymorphisms have been implicated in
            genetic  mechanisms  responsible  for  proper  NK  development  and   the pathogenesis and progression of autoimmune disease. For example,
            function.  Many  syndromes  have  been  linked  to  increased  suscep-  a T → G substitution at position 559 in the FcγRIIIA (CD16) gene
            tibility  to  infection,  and  others  may  predispose  to  autoimmune     leads to a phenylalanine-to-valine substitution at residue 176 of the
                                                                               98
            disease.                                              FcγRIIIA  protein.   Although  the  receptors  are  expressed  similarly
                                                                  on the cell membrane, the V/V homozygous state is associated with
            Natural Killer Deficiency Syndromes Linked to         a higher affinity for immunoglobulin G (IgG) binding than the F/F
                                                                                                                   99
                                                                  state. The low binding state (F/F) is associated with lupus nephritis.
            Increased Infectious Risks                            Others have confirmed this observation by genetic linkage studies in
                                                                                                 100
                                                                  patients with systemic lupus erythematosis.  Another polymorphism
            The first gene directly implicated in NK deficiency was FCGR3A,   in the FcγRIIIA receptor (158V/F) has been associated with RA in
                                                                                  101
            which codes for FcγRIIIa (CD16) expressed on NK cells. A “T → A”   certain ethnic groups.  This mutation may also be associated with
            substitution at position 230 leads to coding of a lysine residue at posi-  the  development  of  subcutaneous  rheumatoid  nodules  in  patients
                                                                                 101
            tion 48, normally a histidine. Although the protein expressed appears   with established RA.  Because CD16 is expressed on a number of
            phenotypically normal, patients present with increased susceptibility   immune cells, the specific role of NK cells contributing to pathology
                                                             84
            to severe and disseminated herpes simplex virus (HSV) infections.    is  unclear;  however,  as  discussed  later,  these  polymorphisms  have
            Other patients present with progressive Epstein-Barr virus and vari-  also been linked to an enhanced response to monoclonal antibody
                       85
            cella infections.  Patients have variable deficits in NK cytotoxicity   therapy for cancer.
   287   288   289   290   291   292   293   294   295   296   297